BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 11172417)

  • 1. VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma.
    Weng WC; Lin KH; Wu PY; Ho YH; Liu YL; Wang BJ; Chen CC; Lin YC; Liao YF; Lee WT; Hsu WM; Lee H
    Sci Rep; 2017 Sep; 7(1):11212. PubMed ID: 28894229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.
    Kim A; Widemann BC; Krailo M; Jayaprakash N; Fox E; Weigel B; Blaney SM
    Pediatr Blood Cancer; 2015 Sep; 62(9):1562-6. PubMed ID: 26207356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin Regulates VEGF-A in Neuroblastoma Cells.
    Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H
    Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytotoxic effects of lipidic formulated gold porphyrin nanoparticles for the treatment of neuroblastoma.
    Lee P; Zhu Y; Yan JJ; Sun RW; Hao W; Liu X; Che CM; Wong KK
    Nanotechnol Sci Appl; 2010; 3():23-8. PubMed ID: 24198467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
    Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
    Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance associated with antiangiogenesis therapy.
    Eikesdal HP; Kalluri R
    Semin Cancer Biol; 2009 Oct; 19(5):310-7. PubMed ID: 19524042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.
    Kim ES; Serur A; Huang J; Manley CA; McCrudden KW; Frischer JS; Soffer SZ; Ring L; New T; Zabski S; Rudge JS; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11399-404. PubMed ID: 12177446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral tumors and neoangiogenesis ].
    Jouanneau E; Bachelot T
    Neurochirurgie; 1999 Nov; 45(4):293-300. PubMed ID: 10599057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenesis in neuroblastoma.
    Ribatti D
    Crit Rev Oncol Hematol; 2013 Jun; 86(3):212-21. PubMed ID: 23273512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor.
    Kim E; Moore J; Huang J; Soffer S; Manley CA; O'Toole K; Middlesworth W; Stolar CJ; Kandel JJ; Yamashiro DJ
    J Pediatr Surg; 2001 Feb; 36(2):287-90. PubMed ID: 11172417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.
    Soffer SZ; Moore JT; Kim E; Huang J; Yokoi A; Manley C; O'Toole K; Stolar C; Middlesworth W; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2001 Aug; 36(8):1177-81. PubMed ID: 11479851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors.
    Huang J; Moore J; Soffer S; Kim E; Rowe D; Manley CA; O'Toole K; Middlesworth W; Stolar C; Yamashiro D; Kandel J
    J Pediatr Surg; 2001 Feb; 36(2):357-61. PubMed ID: 11172434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of primary tumor growth in a mouse model of human neuroblastoma.
    Rowe DH; Huang J; Li J; Manley C; O'Toole KM; Stolar CJ; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2000 Jun; 35(6):977-81. PubMed ID: 10873048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.
    Soffer SZ; Kim E; Moore JT; Huang J; Yokoi A; Manley C; O'Toole K; Middlesworth W; Stolar C; Yamashiro D; Kandel J
    J Pediatr Surg; 2001 Dec; 36(12):1781-4. PubMed ID: 11733906
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.